VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $379,655 | -99.1% | 14,108 | -99.0% | 0.02% | -99.0% |
| Q2 2023 | $42,102,955 | -15.6% | 1,398,304 | -9.3% | 2.34% | -12.6% |
| Q1 2023 | $49,876,080 | +12.6% | 1,541,764 | -0.2% | 2.67% | +7.1% |
| Q4 2022 | $44,286,404 | +12.8% | 1,545,233 | -5.0% | 2.50% | -5.7% |
| Q3 2022 | $39,253,000 | -4.3% | 1,627,392 | +8.6% | 2.65% | -10.7% |
| Q2 2022 | $41,034,000 | -32.2% | 1,498,701 | -5.0% | 2.96% | -33.0% |
| Q1 2022 | $60,486,000 | +21.9% | 1,577,203 | +1.8% | 4.42% | +30.1% |
| Q4 2021 | $49,631,000 | +12.6% | 1,549,513 | +3.6% | 3.40% | -5.7% |
| Q3 2021 | $44,092,000 | -9.6% | 1,496,141 | +4.3% | 3.61% | -8.8% |
| Q2 2021 | $48,759,000 | +9.2% | 1,434,904 | +4.5% | 3.95% | -8.0% |
| Q1 2021 | $44,644,000 | – | 1,373,664 | – | 4.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |